News

PRME ▲ +0.7% - Prime Medicine, Inc.

$PRMECP $3.00▲ +0.7%Oct 5, 2026 · ThinkSabio Blog

PRME ▲ +0.7% - Prime Medicine, Inc. $PRME - Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease 05-OCT-2026 08:00 AM ET

Share this post

More filings for $PRME

PRME ▲ +10.2% - Prime Medicine, Inc.Sep 24, 2026 PRME ▼ -0.5% - Prime Medicine, Inc.Sep 3, 2026

View full $PRME filing history →

💬 Comments

Loading comments…